Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers (Audio Faculty Interviews)


Michael J Birrer, MD, PhD
Winthrop P Rockefeller Cancer Institute
Director, Cancer Service Line
University of Arkansas
Little Rock, Arkansas
Ursula Matulonis, MD
Chief, Division of Gynecologic Oncology
Brock-Wilson Family Chair
Dana-Farber Cancer Institute
Professor of Medicine 
Harvard Medical School 
Boston, Massachusetts
David M O’Malley, MD
Division Director, Gynecologic Oncology
Co-Director, Gynecologic Oncology Phase I Program
The Ohio State University and The James Cancer Center
Columbus, Ohio
Krishnansu S Tewari, MD
Professor and Division Director
Division of Gynecologic Oncology
University of California, Irvine
Irvine, California
Neil Love, MD
Research To Practice
Miami, Florida